ヨーロッパの迷走神経刺激市場 – 2031 年までの業界動向と予測

ヨーロッパの迷走神経刺激市場の分析と規模

迷走神経は、代謝恒常性を調節する自律神経系の重要な構成要素であり、求心性および遠心性の経路を介して恒常性を維持する神経内分泌免疫軸の重要な構成要素として機能します。手動または電気刺激を含む迷走神経を刺激するあらゆるアプローチは、迷走神経刺激 (VNS) と呼ばれます。難治性てんかんおよび治療抵抗性うつ病の場合、左頸部 VNS は承認された治療法です。

データブリッジ市場調査は、ヨーロッパの迷走神経刺激市場は2023年に2億4,134万米ドルと評価され、予測期間中に15.6%のCAGRで成長し、2031年には8億9,134万米ドルに達すると予測しています。迷走神経刺激の需要が高まっているため、「埋め込み型VNSデバイス」が市場の製品タイプセグメントを支配しています。データブリッジ市場調査がまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要企業などの市場シナリオに関する洞察に加えて、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

ヨーロッパの迷走神経刺激市場の範囲とセグメンテーション

Market Definition

The vagus nerve is a long cranial nerve that runs from a person’s brain stem into the neck, chest, and abdomen. It is a part of the parasympathetic nervous system, which is commonly referred to as the rest-and-digest system because it regulates body functions while a person is at rest. It delivers messages to a person’s brain from their digestive system and organs such as their lungs, heart, and liver. It controls several organ functions, including digestion, heart rate, and respiratory rate. It is responsible for vasomotor activity and reflexes. It also regulates vocalization, mood, and immunity. It influences sensory functions in a person’s ears, sinuses, and esophagus as well.

Europe Vagus Nerve Stimulation Market Dynamics

Drivers

• Increasing Prevalence and Incidence of Neurological Disorders

Neurological disorders cause 4.5% to 11% of all illnesses, whether in low or high-income countries. The impact is greater compared to that of malignancies, gastrointestinal diseases, or respiratory illnesses, and it is expected to grow over the next years. One of the most common neurological conditions, epilepsy, affects almost every country on earth. Most people with this illness are seen in high-population countries. Due to this rising prevalence, there is a rising demand for a variety of tools and treatments, such as VNS. More neurological problems are being treated with VNS. In addition to other clinical uses, it aids in the treatment of neurological conditions like epilepsy and depression due to the significant prevalence of neurological conditions worldwide.

• Introduction of Innovative non-invasive vagus nerve stimulation devices

Traditional and conventional VNS devices are implanted in the patient's body and leads are placed on the vagus nerves that provide electrical stimulation when required. Growing demand and technological advancement of innovative devices lead to the introduction of small-sized implantable VNS devices in the market. These small-sized implantable devices offer various clinical benefits to patients and healthcare providers. The introduction of innovative devices is anticipated to boost the market growth.  

Opportunities

• Strategic initiatives by the key market players

The demand for VNS devices is increasing in the market owing to the increased levels of R&D; along with that, the market growth is being aided by the desire for innovative medications. Thus, the top market players have implemented new strategies by developing new devices and equipment as well as collaborating with other players in the market and aimed at improving business operations and profitability. Increasing strategic initiatives by key market players are expected to offer significant opportunities for market players operating in the market.

• Rising government initiatives for neurological disease

The purpose of funding for VNS devices is to encourage applications seeking to develop devices for various neurological disorders. The funding by the government would result in the safety of the patient and cost savings. In addition, hospitals and healthcare agencies would administer this treatment at a lower price through collaboration with government organizations. Hence, the advancements in R&D activities and funding by the government will act as an opportunity for this market growth. 

Restraints/Challenges

• High Maintenance and Device Costs

The rise in the cost of VNS devices is due to technological development and increased demand for nVNS devices by neurologists in hospitals, clinics, nursing facilities, and ambulatory surgical centers. Overhead costs can help explain why hospitals charge so much for stimulation devices. The increased intricacy and cost of VNS devices, technological innovations, and robust investments would increase the costs. The increased cost would result in delayed treatment of patients in hospitals and clinics. Hence, the increased cost of VNS devices is expected to restrain market growth

• High Cost Associated with R&D

The high cost associated with the research and development proficiencies, limited infrastructural facilities, high cost associated with the chemical analyser in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, heavy custom duty imposed on the medical devices, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market.

This vagus nerve stimulation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vagus nerve stimulation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In May 2022, electroCore, Inc. announced that the gammaCore Sapphire non-invasive Vagus Nerve Stimulator will be available in 130 National Spine and Pain Centers (NSPC) affiliated locations across the U.S. for patients suffering from pain associated with different forms of primary headache. This would help the organization to develop more revenue

Europe Vagus Nerve Stimulation Market Scope

The vagus nerve stimulation market is segmented on the basis of product type, biomaterial, application, patient type, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Implantable VNS Devices
• External VNS Devices

Biomaterial

• Ceramics
• Metallic
• Polymeric

Application

• Pain Management
• Epileptic Seizures
• Obesity Management
• Depression and Anxiety
• Others

Patient Type

• Adults
• Pediatric
• Geriatric

End User

• Hospital
• Ambulatory Surgery Centers
• Specialty Centers
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Others

Europe Vagus Nerve Stimulation Market Regional Analysis/Insights

The vagus nerve stimulation market is analyzed and market size insights and trends are provided by country, product type, biomaterial, application, patient type, end user, and distribution channel as referenced above.

The countries covered in the market report are U.K., Germany, France, Italy, Spain, Netherlands, Switzerland, Belgium, Sweden, Denmark, Norway, Finland, Austria, Ireland, and rest of Europe.

U.K. is expected to dominate the market due to the strong base of healthcare facilities, strong presence of major players in the market, increases cases of cardiovascular disease among and rising number of geriatric population in this region.  

Germany is expected to be the fastest growing country in the market due to rising technological advancements with increasing strategic initiatives among the key players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The vagus nerve stimulation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for vagus nerve stimulation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vagus nerve stimulation market. The data is available for historic period 2011-2022.

Competitive Landscape and Vagus Nerve Stimulation Market Share Analysis

The vagus nerve stimulation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vagus nerve stimulation market.

Some of the major players operating in the vagus nerve stimulation market are:

• Philips Healthcare (Netherlands)
• GE Healthcare (U.S.)
• Siemens Healthineers (Germany)
• Hillrom Holdings, Inc. (U.S.)
• Schiller AG (Switzerland)
• Fukuda Denshi Co., Ltd. (Japan)
• Mindray Medical International Limited (China)
• Nihon Kohden Corporation (Japan)
• Mortara Instrument, Inc. (U.S.)
• BPL Medical Technologies (India)
• Medtronic plc (U.S.)

SKU-69404